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 1 
Abstract  2 
Objectives  3 
To compare the clinical outcomes of adolescents and young adults with anorexia 4 
nervosa (AN) co-morbid with broad autism spectrum disorder (ASD) or ASD traits.  5 
Method   6 
The Developmental and Well-Being Assessment (DAWBA) and Social Aptitude 7 
Scale (SAS) were used to categorise adolescents and young adults with AN (N=149) into 8 
those with ASD traits (N=23), and those who also fulfilled diagnostic criteria for a 9 
possible/probable ASD (N=6).  We compared both eating disorders specific measures and 10 
broader outcome measures at intake and twelve months follow-up.  11 
Results 12 
Those with ASD traits had significantly more inpatient/day-patient service use (p= 13 
.015), as well as medication use (p<.001) at baseline. Both groups All patients had high 14 
social difficulties and poorer global functioning (SDQ) at baseline , which improved over 15 
time but remained higher at 12 months in the ASD traits group (p= .002). However, the 16 
improvement in eating disorder symptoms at 12 months was similar between groups with or 17 
without ASD traits. Treatment completion rates between AN only and ASD traits were 18 
similar (80.1 vs. 86.5%).  19 
Conclusion 20 
Adolescents with AN and ASD traits show similar reductions in their eating disorder 21 
symptoms. Nevertheless, their social difficulties remain high suggesting that these are life-22 
long difficulties rather than starvation effects.  23 
 3 
Introduction  1 
 2 
Neurodevelopmental disorders have been associated with Eating Disorders (ED), with 3 
Attention-Deficit / Hyperactivity Disorder linked to Bulimia Nervosa (BN) and Binge Eating 4 
Disorder (BED) (Nazar et al., 2016), and Autism Spectrum Disorders (ASD) to Anorexia 5 
Nervosa (AN) (Baron-Cohen et al., 2013; Tchanturia et al., 2013). There has been interest in 6 
the impact these might have upon treatment and prognosis (Westwood & Tchanturia, 2017).  7 
 8 
In a Swedish cohort of AN adolescents, 32% had ASD traits at some time over the course of 9 
18 years follow-up and this sub-group had a poorer long term prognosis (Anckarsäter et al., 10 
2012), with particular problems in mental and social functioning (Nielsen et al., 2015). In a 11 
series of AN cases referred to a specialized child and adolescent service, 6.9% had broad 12 
ASD traits (using the Autism-Spectrum Quotient [AQ]) and this sub-group were more likely 13 
to progress to more intensive levels of care (day or inpatient) (Stewart, McEwen, 14 
Konstantellou, Eisler, & Simic, 2017). In line with these findings, we have previously 15 
reported that 19% of AN adolescents presenting for treatment had ASD traits with 4% 16 
receiving a probable/possible ASD diagnosis (Rhind et al., 2014). These findings suggest that 17 
people with AN and associated ASD traits may have a less favorable prognosis.  18 
 19 
We therefore aimed to examine the 12 months outcomes of patients who had ASD traits and 20 
those with a probable/possible ASD diagnosis in a sample of individuals with AN 21 
participating in a randomized controlled trial.  22 
 23 
Method 24 
 4 
The present report is a secondary data analysis from the Experienced Carers Helping Others 1 
(ECHO) trial. This trial aimed to assess the benefits of a carer intervention added to usual 2 
treatment, where they received materials and telephone coaching to better cope with their 3 
offspring’s ED.    4 
 5 
Participants were aged between 13-21 and consisted of 149 adolescents with AN or Atypical 6 
AN, among which, 15.4% had ASD traits and 4% received a possible/probable ASD 7 
diagnosis. Some baseline features have been described previously (Rhind et al., 2014) as well 8 
as details regarding the original trial (Hibbs et al., 2015).  9 
 10 
Assessment Measures  11 
Details regarding measures can be found in the Supplementary materials and are summarised 12 
below: 13 
The Developmental and Well-being Assessment (DAWBA) (Goodman, Ford, Richards, 14 
Gatward, & Meltzer, 2000). Both parent and patients completed the ED and ASD modules 15 
for this computerized diagnostic instrument and trained psychiatrists confirmed the 16 
psychiatric diagnosis afterwards (DSM-IV (American Psychiatric Association, 2000) and 17 
ICD-10 (World Health Organization, 1993).  18 
Strengths and Difficulties Questionnaire (SDQ) (Goodman & Scott, 1999). An instrument 19 
with five sub-scales (peer problems, prosocial difficulties, hyperactivity, emotional problems, 20 
and conduct problems), completed both by parent and patients at baseline and 12 months. 21 
 5 
Social Aptitude Scale (SAS)(Liddle, Batty, & Goodman, 2009). Parents report 1 
retrospectively on their child's social development comparing their child’s abilities to those of 2 
their peers, completed at baseline only. 3 
The Short Evaluation of Eating Disorders (SEED) (Bauer, Winn, Schmidt, & Kordy, 2005).  4 
A 6-item measure of ED symptom severity. The outcomes include a three items severity 5 
score for AN (ANTSI) and three items for BN (BNTSI). The score from each item can range 6 
from 0 to 3 (0 = symptom not present; 3 = symptom is extreme).  7 
The Depression, Stress and Anxiety Scale (DASS-21) (Henry & Crawford, 2005). A 8 
shortened version of the DASS with good internal consistency on each of the sub-scales.   9 
 10 
Statistical Analyses  11 
Statistical analyses were completed using IBM SPSS Statistics Version 22. The sample was 12 
divided into two sub-groups (mutually exclusive) based on scores on the SAS using standard 13 
cut off criteria (Liddle, Batty, & Goodman, 2009): (1) AN only (SAS above 16) (n=126); (2) 14 
broad ASD traits (n=23). Among the latter group, six individuals formed the ASD diagnosis 15 
subset which was also compared to AN only.  16 
As the group with broad ASD traits is small, we report Cohen’s d effect sizes to indicate the 17 
magnitude of differences between groups. Cohen’s effect sizes are understood as negligible 18 
(<0.15), small (0.15 < d <0.40), medium (0.40 < d < 0.75), large (0.75 < d).  19 
Mann-Whitney U tests compared differences between sub-groups where the data was non-20 
parametrically distributed. Chi-square tests were performed for comparing proportions and 21 
Spearman correlations for non-parametric associations.   22 
 6 
 1 
Results  2 
The baseline sociodemographic characteristics are presented in Table 1 and the clinical 3 
characteristics are presented in Table 2. Regarding ECHO treatment allocation, there were no 4 
significant differences between AN only and broad ASD traits groups (X2 =.077 ; p = .782). 5 
Participants with broad ASD traits had had more general inpatient and day-patient days (U= 6 
1077.0, z = 2.433, p = .015) and had been more frequently admitted to an ED specialist 7 
inpatient treatment (18.2% vs 5%; (X2 =6.62 ; p = .02). Furthermore, the ASD group 8 
presented with more antipsychotic use (X2=11.74; p< .001) prior to presentation. Baseline 9 
SAS scores were significantly and inversely correlated with baseline antipsychotic use in the 10 
total sample (rho= - .21; p= .017). At baseline, ED symptoms were similar between groups 11 
but the group with broad ASD traits had higher parental (p<.0001) and self-reported (U= 12 
795.5, z= -2.16, p= .03) total general difficulties on the SDQ.  13 
There was no significant difference (X2 = .588; p= .44) between the proportion of participants 14 
who completed the 12 month follow-up in the AN only (80.1%) and the broad ASD traits 15 
group (86.95%). Both groups had similar increases in BMI and weight for height from 16 
baseline to 12 months, as well as similar reductions in ED symptoms. After 12 months, there 17 
were no differences between the groups in medication use (X2= 2.44; p= .111) (Table 1). 18 
Both groups had decreases in general difficulties (SDQ) over time. However, those in the 19 
ASD group continued to have a higher level of total general difficulties (SDQ) at 12 month 20 
(U= 49.0, z= -3.10, p= .002). Parents, in general, reported higher levels of problems than the 21 
patients themselves but there was convergence between parent (U= 485.0, z= -3.23, p= 22 
.0001) and patient reports (U= 280.0, z= -3.68, p < .0001).  Significantly higher general 23 
difficulties ( SDQ) among those in the ASD traits group were found for both parent (U= 24 
 7 
497.0, z= 4.24, p< .0001) and self-report (U= 795.5, z= -2.16, p= .03), and for the subscale 1 
peer difficulties (SDQ), both on parent (U= 422.0, z= -4.56, p< .0001) and self-report (U= 2 
629.5, z= -3.25, p< .0001). SDQ results are presented in Table 3 for AN only versus Broad 3 
ASD traits group, and SDQ data from the ASD subset is presented in a different version of 4 
this table on the  Supplementary materials.  5 
 6 
The ‘ASD probable /possible diagnosis’ subgroup  7 
The social difficulties of the six participants (five possible, one definite) with an ASD 8 
diagnosis improved over time (d= 2.02; p= .03) but, as expected, remained higher than in the 9 
other group of patients. Other domains of difficulties also improved (Table 2).  10 
We obtained an update on the clinical functioning of these six possible cases at two-years 11 
post intake. Four of them had continued in treatment; one had persistent AN and low weight 12 
(BMI = 15.7 kg/m2); another transitioned to Bulimia Nervosa and eventually reached a BMI 13 
of 25kg/m2.  One patient experienced continuing social and mood problems and another 14 
severe OCD. The remaining two were not in treatment and were presumed to be well. 15 
 16 
Discussion  17 
The aim of this study was to examine the clinical course of young people with AN who also 18 
had ASD traits (broad and narrow/diagnostic). The ASD traits group had a greater use of 19 
intensive treatment (in/day-patient) and medication use before presentation to the specialist 20 
clinic and more general difficulties ( SDQ), both at baseline and after receiving specialist 21 
treatment. However, eating disorder symptoms (BMI, weight for height and SEED) in the 22 
broad and narrow/diagnostic groups did not differ from the comparison group both at 23 
 8 
baseline and at 12 months. The majority of the narrow/diagnostic group continued to have 1 
contact with mental health services two years after presentation, two of whom had a 2 
persistent eating disorder. A poorer prognosis in the ASD group appears to relate to the more 3 
severe general comorbidity than to the eating disorder outcomes alone.  4 
   5 
The 15.4% (23/149) prevalence of SAS scores below cut-off (ASD traits group) in this 6 
sample is the same as that found in a clinical cohort of AN and EDNOS cases (Stewart et al., 7 
2017). However, the computer generated probability of ASD diagnosis from the DAWBA in 8 
the clinical cohort (Stewart et al., 2017) did not differ from community norms, whilst in our 9 
sample, a trained psychiatrist reviewed the DAWBA and we found one probable and five 10 
possible cases (Rhind et al., 2014). There were differences in the clinical specifiers between 11 
these studies., . The clinical cohort (Stewart et al., 2017) included people with an age range of 12 
9-18 (mean=14.6), whereas the current study included people from age 13-21 years 13 
(mean=17). Previous studies suggest that the prevalence of ASD traits varies according to the 14 
age/duration of illness of the sample included. For example, in a recent meta-analysis lower 15 
levels of ASD traits were reported  in children/adolescents than in adult samples (Westwood 16 
et al., 2016). Also, the number of cases who met diagnostic criteria for ASD was higher in 17 
inpatients with a more severe form of illness (Wentz et al., 2005). 18 
  19 
In this study we found that although ED related symptoms and physical recovery did not 20 
differ between  groups, there was a greater severity of residual general  comorbidity in the 21 
group with ASD. The group with ASD traits had had more intensive treatment at baseline and 22 
a large proportion of those with probable/possible diagnosis remained in treatment. In the 23 
Swedish cohort followed up over 30 years, participants with ASD traits were found to have a 24 
poorer global outcome (using Morgan and Russell scales) (Nielsen et al., 2015). Inpatients 25 
 9 
with ASD traits and/or diagnosis also didn’t improve as much as their non-ASD counterparts 1 
from group Cognitive Remediation Therapy (Tchanturia, Larsson, & Adamson, 2016). 2 
Interestingly, this study found that although people with ASD engaged with treatment as 3 
much as non-ASD, the same was found in another adult inpatient sample (Huke, Turk, 4 
Saeidi, Kent, & Morgan, 2014) 5 
   6 
 7 
Clinical Implications 8 
 9 
Patients with ASD comorbidity have a poorer global outcome (with residual problems that 10 
relate to their ASD traits), although eating symptoms do appear for the most part to respond 11 
to standard care. It is possible that this group need a form of psychosocial intervention which 12 
focuses more on social identity and functioning (McNamara & Parsons, 2016). For example, 13 
the addition of the New Maudsley method of collaborative care, which equips families with 14 
skills training to improve their understanding and support for the individual, was found to 15 
improve peer functioning and prosocial behavior in AN patients (Hibbs et al., 2015). 16 
   17 
Strengths and Limitations  18 
A major strength of this study was the use of multimodal and multi-informant assessments 19 
measures (DAWBA; SAS; SDQ) and the setting within a RCT with repeated assessment 20 
measures (e.g. monthly weight measures). Nevertheless, given the low prevalence of ASD 21 
traits, the study may not have had sufficient power to detect different outcomes. Also, a full 22 
cost effectiveness analysis has not been completed. Although this study was representative of 23 
adolescents with AN presenting across the UK, there may have been a degree of selection, as 24 
carers had to agree to participate in order for adolescents to be included in the study. Also, we 25 
 10 
didn’t use a structured clinical interview with patients to diagnose ASD and we didn’t control 1 
for the presence of other comorbidities. Finally, the use of a 6-item assessment (SEED) might 2 
have impaired our analysis as it didn’t cover all the aspects of ED symptomatology.  3 
 4 
Conclusion 5 
For the most part, the eating disorder symptoms in adolescents/young adults with AN and 6 
ASD traits resolve in the same time frame, and to the same degree, as those of people with 7 
AN without such traits. Continuing problems in social and emotional functioning occurred in 8 
those with broad ASD traits and those with an ASD diagnosis.  9 
 10 
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 35 
Assessment Measures  
Patient Assessment Measures. Patients and their parents completed a variety of 
structured interviews and self-report instruments to assess sociodemographic features, 
ED symptoms (BMI, SEED), broader clinical characteristics (DAWBA, SDQ, SAS, 
DASS-21), and clinical service use (CSRI) at intake, 6-months, and 12-months. These 
are all described below 
The Developmental and Well-being Assessment (DAWBA).  This is validated measure 
which generates DSM-IV and ICD-10 psychiatric diagnosis (Goodman, Ford, 
Richards, Gatward, & Meltzer, 2000).  It has excellent discrimination between clinical 
and healthy cases (McEwen et al., 2016). In the present study, parents (informants) and 
patients independently completed the autism spectrum diagnostic (ASD) and eating 
disorders (ED) sections. The computerised interview includes screening questions and 
skip rules, as well as a free text component (Angold et al., 2012). The strengths and 
difficulties questionnaire (SDQ) and the social aptitude scale (SAS) form part of the 
assessment (see below). Afterwards, the computer generates a probability diagnosis 
that falls into any of six bands, ranging from less than 0.1% or up to 70% chance of a 
diagnosis. Finally, a psychiatrist trained in the instrument produces the final diagnostic 
assessment using all of these sources of information. Clinician ratings of the DAWBA 
were only available at intake. 
 Strengths and Difficulties Questionnaire (SDQ). A 25 items self-report questionnaire 
on psychological attributes, with five subscales with five questions each (peer 
problems, prosocial difficulties, hyperactivity, emotional problems, and conduct 
problems) and seven scores (the five subescales, total score and impact from total 
score). It is completed both by informants, in this case parents  (I = informants), and by 
patients (SR = self-reports). It has satisfactory reliability (internal consistency: α = .73, 
cross-informant correlation:  α = .34, and retest stability: α = .62) (Johnson, Hollis, 
Marlow, Simms, & Wolke, 2014). It is frequently used to compare groups and as a 
“before” and “after” measure instead of being given a cut-off (Goodman & Scott, 
1999).  
Social Aptitude Scale (SAS). This is a 10 item measure completed by informants on 
their child's retrospective social development.  It explores behaviours representative of 
their social aptitude and peer relationships, in real life situations that demand complex 
social responses. Parents compare their child’s abilities to their peers, answering 
whether they are “a lot worse than average”, “a bit worse than average”, “about 
average”, “a bit better than average”, or “a lot better than average”, which are graded 
on a likert scale from 0 to 4,  on items such as “Can work out what people are really 
thinking and feeling”. The lowest possible score is 0 and the highest 40. A score of 
below 16 is suggestive of an ASD diagnosis with a sensitivity of .93 and a specificity 
of .93, a positive predictive value of .104 and a negative predictive value of .999. Thus, 
it can be used to investigate ASD traits or to screen for an ASD diagnosis. This measure 
taps into different constructs than the SDQ and has low to moderate correlation with it. 
(Liddle, Batty, & Goodman, 2009). 
The Short Evaluation of Eating Disorders (SEED) A 6-item measure of ED symptom 
severity. The outcomes include a separate severity score for Anorexia Nervosa 
(ANTSI) (3 items) and Bulimia Nervosa (BNTSI) (3 items). The score from each item 
can range from 0 to 3 (0 = symptom not present; 3 = symptom is extreme). A cut-off 
score hasn’t been suggested by authors (Bauer, Winn, Schmidt, & Kordy, 2005).  
The Depression, Stress and Anxiety Scale (DASS-21 )(Lovibond & Lovibond, 1995). 
A shortened version of the DASS-42 with good internal consistency on each of the 
three subscales (Depression, Anxiety and Stress).  The subescales have 7 items each 
and are presented in a likert scale ranging from 0 to 3. It has been validated in the British 
population and all subescales have shown good internal consistency (Henry & 
Crawford, 2005).  
Parent Measures  
The Client Service Receipt Inventory (CSRI).  A structured telephone interview 
conducted by clinical assessors CR and RH measuring use of specialist and generic 
health services completed by both the patient and parent.  It was used to assess the 
duration (in weeks) and frequency (days/week) of both formal and informal care 
(adapted for this study). We divided service use into five categories: all inpatient or day 
patient days; visits to a GP, Practice Nurse (PN) or A&E; outpatient visits (dietician, 
psychologist, counsellor, ED group therapy, psychotherapist, community/other 
psychiatric nurse, alternative therapy, crisis intervention, or occupational therapist), 
family-related services (FBT, outreach, and social worker visits), and all other help 
(self-help, support groups, telephone help lines, message boards, and print/Internet 
sources).  
  
 Supplementary version of Table 3  - SDQ results across groups including ASD 
subset 
 
Diagnostic 
group 
Baseline 
mesures 
12 months 
measure 
Cohen’s d 
(p-value) 
Baseline vs 
12 months 
Cohen’s d 
AN only vs 
AN+Broad 
ASD 
(Baseline 
and 12-
months) 
Strengths and Difficulties Questionnaire (Self report) 
Total score 
AN only 
16.6 (+5.6) 
N = 108 
14.8 (+6.6)  
N = 76 
.31 
(p= .007)  
.06 
AN+Broad 
ASD 
19.5 (+7.0) 
N = 22 
18.1 (+5.4) 
N = 18 
.29 
(p= .058) 
ASD subset  
18.8 
(+6.43) 
N=6 
17.33 (+8.14) 
N=6 
1.20 
(p= .23) 
N.A. 
Impact from 
total score 
AN only 
4.3 (+3.4) 
N = 108 
2.6 (+3.0)  
N = 76 
.51 
(p< .001) 
.51 
AN+Broad 
ASD 
4.6 (+3.8) 
N = 22 
4.7 (+3.5)  
N = 18 
- .03 
(p= .94) 
ASD subset  
4.6 (+3.32) 
N=6 
4 (+ 3.4)  
N=6 
.26 
(p= .25) 
N.A. 
Emotional 
Symptoms 
AN only 
6.6 (+2.2) 
N = 108 
5.6 (+2.7) 
N = 76 
.41 
(p< .001) 
.13 
AN+Broad 
ASD 
6.9 (+2.7) 
N = 22 
6.2 (+2.9) 
N = 18 
.35 
(p= .39) 
ASD subset  
6.3 (+ 
2.65) N=6 
5.8 (+ 3)  
N=6 
.28 
(p= .45) 
N.A. 
Hyperactivity 
AN only 
5 (+2.1) 
N = 108 
4.4 (+2.3) 
N = 76 
.29 
(p= .032) 
0 
AN+Broad 
ASD 
5.3 (2.1) 
N = 22 
4.7 (1.9) 
N = 18 
.32 
(p= .16) 
ASD subset  
5.5 (+ 
2.25) N=6 
4.3 (+2.42) 
N=6 
1.49 
(p= .10) 
N.A. 
Peer 
Problems 
AN only 
2.9 (+1.9) 
N = 108 
2.9 (+1.8)  
N = 76 
0 
(p= .84)  
.25 
AN+Broad 
ASD 
4.6 (+ 2.2) 
N = 22 
5.1 (+ 2.0)  
N = 18 
- .29 
(p= .97) 
ASD subset  
4.6 (+ 2.58) 
N=6 
5.5 (+ 2.16) 
N=6 
- .61 
(p= .12) 
N.A. 
Conduct 
Problems 
AN only 
2.1 (+1.6) 
N = 108 
1.9 (+1.6) 
N = 76 
.11 
(p= .18) 
- .18 
AN+Broad 
ASD 
2.7 (+1.9) 
N = 22 
2.2 (+1.6) 
N = 18 
.36 
(p= .09) 
ASD subset  
2.3 (+1.86) 
N=6 
1.6 (+1.63) 
N=6 
.56 
(p= .15) 
N.A. 
Prosocial 
AN only 
8.0 (+1.6) 
N = 108 
7.6 (+2.1)  
N = 76 
.20 
(p= .02) 
.17 
AN+Broad 
ASD 
7.5 (+2.0) 
N = 22 
7.4 (+1.9)  
N = 18 
.06 
(p= .49) 
ASD subset  
7.3 (+.81) 
N=6 
7.5 (+1.51) 
N=6 
- .52 
(p= .56) 
N.A. 
Strengths and Difficulties Questionnaire (Parent report) 
Total score 
AN only 
14.8 (+6.6) 
N = 100 
 
12.4 (+6.9) 
N = 84 
.38 
(p= .015) 
 
- .15 
AN+Broad 
ASD 
20.6 (+5.4) 
N = 23 
17.2 (+4.9) 
N=22 
.55 
(p= .006) 
ASD subset 
20.6 (+5.92) 
N=6 
16.3 (+6.43) 
N=6 
2.02 
(p= .03) 
N.A. 
Impact from 
total score 
AN only 
3.5 (+3.1) 
N = 100 
3.0 (+3.4) 
N = 84 
.14 
(p= .102) 
- .22 
AN+Broad 
ASD 
5.6 (+2.9) 
N = 23 
4.4 (+3.1) 
N=22 
.32 
(p= .112) 
ASD subset 
6.6 (+1.5) 
N=6 
4.1 (+2.71) 
N=6 
.79 
(p= .104) 
N.A. 
Emotional 
Symptoms 
AN only 
6.2 (+2.5) 
N = 100 
5 (+2.8) 
N = 84 
.44 
(p= .001) 
- .04 
AN+Broad 
ASD 
7.7 (+1.4) 
N = 23 
 
6.4 (+2.2) 
N=22 
.64 
(p= .009) 
ASD subset 
7.8 (+1.32) 
N=6 
6.5 (+2.88) 
N=6 
.56 
(p= .22) 
N.A. 
Hyperactivity 
AN only 
3.7 (+2.3) 
N = 100 
3.6 (+2.6) 
N = 84 
.04 
(p= .47) 
.04 
AN+Broad 
ASD 
4.4 (+2) 
N = 23 
4.4 (+1.8) 
N=22 
0 
(p= .62) 
ASD subset 
4.3 (+2.33) 
N=6 
3.5 (+2.34)  
N=6 
.41 
(p= .059) 
N.A. 
Peer 
Problems 
AN only 
2.5 (+2.1) 
N = 100 
2.1 (+1.6) 
N = 84 
.23 
(p= .26) - .24 
    
 
Legend: N.A. = Not Applicable; SDQ = Strengths and Difficulties Questionnaire; 
ASD = Autism Spectrum Disorder 
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 Table 1. Sociodemographic characteristics 
Legends: * = p-value of Mann-Whitney tests for medians or Chi-squares for 
frequencies; **= significant at the <.05 level ***=significant at the <.001 level  
 
AN only 
(SAS>16) 
N= 126 
AN+Broad ASD 
(SAS< 16) 
N =23 
AN only vs. 
AN+Broad 
ASD 
differences 
(Cohen’s d; 
p-value)* 
ASD subset 
N=6 
Total 
sample 
N=149 
Gender 
(Male:Female; 
%Female) 
11:115  
(91.26%) 
1:22  
(95.65%) 
.16; .47 
0:6  
(100%) 
12:137  
(91.94%) 
Age at baseline 
(years) Mean 
(SD) 
16.9 (+2.2) 17.0 (+2.0) .04; .84 
16.97 
(+1.76) 
16.9 (+2.1) 
Education in 
years 
11.75 (+2.05) 11.7 (1.67) .02; .95 
11.83 
(+1.72) 
11.7 (+2) 
Age of onset in 
years (median, 
range) 
14.0 (11.0-20.0) 14.3 (7.0 -19.0) .12; .39 15 (7-16) 
14.0  (7.0-
20.0) 
Age of diagnosis 
in years 
(median,range) 
15.0 (12.0-21.0) 15.5 (13.0-20.0) .11; .95 
15.0 (13.0-
20.0) 
15.0 (12.0-
21.0 ) 
Lowest BMI 15.4 (+2.11) 15.7 (+2.6) - .13; .67 
14.68 
(+1.03) 
15.5 (+2.21) 
Illness duration 
in months  
21.92 (+22.19) 24.69 (+23.7) - .12; .58 
17.83 
(+15.8) 
22.34 
(+22.37) 
Employment p-value 
Full- or part-time 10 (7.9%) 2 (8.6%%) .85 0% 12 (8.1%) 
Students 105 (83.3%) 20 (87%) .36 6 (100%) 125 (83.9%) 
Other 11 (8.7%) 1 (4.3%) .47 0% 12 (8.1%) 
Living Arrangements at Intake p-value 
With parents 116 (92.1%) 21 (95.5%) .64 6 (100%) 137 (91.9%) 
Alone 0 1 (4.5%) .01** 0% 1 (0.6%) 
Friends/flatmates 4 (3.2%) 0 .39 0% 5 (3.4%) 
Uni residence 4 (4.0%) 0 .39 0% 5 (3.4%) 
Other 1 (0.8%) 0 .67 0% 1 (0.6%) 
 
Table 2. Comparisons of clinical characteristics from baseline to 12 month follow up 
 Groups Baseline 
12 month 
Follow Up 
Effect Size 
-Cohen’s 
d (p-
value) 
Effect 
Size 
(Cohen’s 
d) 
BMI 
AN only 
17.0 (+2.2) 
N=126 
18.7 (+2.4) 
N=101 
- .73 
(p< .001) 
.08 
AN+Broad 
ASD 
17.3 (+2.6) 
N=23  
19.2 (+3.1) 
N=20 
- .94 
(p= .001) 
ASD 
subset  
16.74 (+2.53) 
N=6 
18.58 (+2.3) 
N=6 
-1.01 
(p= .04) 
N.A. 
Weight for 
Height 
AN only 
82.4 (+11.0) 
N=114 
88.6 (+11.8) 
N=98 
- .52 
(p< .001) 
.07 
AN+Broad 
ASD  
82.9 (+13.3) 
N=22 
90.9 (+15.8) 
N=20 
- .82 
(p= .003) 
ASD 
subset  
77.09 (+10.33) 
N=6 
87.61 
(+11.58) 
N=6 
-1.05 
(p= .13) 
N.A. 
ANTSI 
AN only 
1.9 (+.6) 
N=121 
1.4 (+.7) 
N=83 
.76 
(p< .001) 
0 
AN+Broad 
ASD  
1.8 (+.6) 
N=23 
1.3 (+.7) 
N=16 
.68 
(p= .005) 
ASD 
subset  
1.91 (+ .75) 
N=6 
1.33 (+ .76) 
N=6 
.75 
(p= .11) 
N.A. 
BNTSI 
AN only 
.8 (+.6) 
N=113 
.5 (+ .6) 
N=107 
.48 
(p< .001) 
.52 
AN+Broad 
ASD  
.6 (+ .4) 
N=22 
.6 (+ .6) 
N=21 
0 
(p= .95) 
ASD 
subset  
.37 (+.34) 
N=6 
.41 (+.46) 
N=6 
- .09 
(p= .67) 
N.A. 
DASS-21 
AN only 
65.7 (+31.1) 
N=125 
49 (+31.2) 
N=91 
.54 
(p< .001) 
.41 
AN+Broad 
ASD  
63.1 (+29.4) 
N=23 
59.3 (+34.9) 
N=19 
.01 
(p= .77) 
ASD 
subset  
61.3 (+34.14) 
N=6 
55.33 
(+28.61) 
N=6 
.18 
(p= .50) 
N.A. 
Using 
psychotropic 
medication  
N (%) # 
AN only 
27 (21.4%) 
N= 125 
41 (32.5%) 
N= 89 
.53 
(p< .001) .28
** 
(small 
effect) AN+Broad 
ASD  
8 (36.4%) N= 
22 
12 (54.5%) 
N= 12 
.63 
(p = .056) 
ASD 
subset  
2 (33.3%) 
N=6 
3 (50%) 
N=6 
N.A. 
Antidepressants 
AN only 
26 (20.6%) 
N= 126 
37 (29.4%) 
N= 90 
.45 
(p< .001) .20** 
(small 
effect) AN+Broad 
ASD  
5 (22.7%)  
N= 22 
9 (40.9%) 
N=18 
.59  
(p= .07) 
ASD 
subset  
2 (33.3%) 
N=6 
3 (50%) 
N=6 
N.A. 
Antipsychotics 
AN only 
1 (0.8%) 
N= 126 
8 (6.3%) 
N=91 
.40 
(p = .003) .08** 
(no 
effect) AN+Broad 
ASD  
3 (13.6%)  
N=22 
1 (4.5%) 
N=18 
.27 
(p= .39) 
ASD 
subset  
0 (0%) 
N=6 
1 (16.7%) 
N=6 
N.A. 
 Legend:  # = From total percentage including missing data; Cohen’s q = calculated by 
the correlation difference as suggested by Cohen, 1988; 
 
Diagnostic 
group 
Baseline 
mesures 
12 months 
measure 
Cohen’s d 
(p-value) 
Baseline vs 
12 months 
Cohen’s d 
AN only vs 
AN+Broad 
ASD 
Strengths and Difficulties Questionnaire (Self report) 
Total score 
AN only 
16.6 (+5.6) 
N = 108 
14.8 (+6.6)  
N = 76 
.31 
(p= .007)  
.06 
AN+Broad 
ASD 
19.5 (+7.0) 
N = 22 
18.1 (+5.4) 
N = 18 
.29 
(p= .058) 
ASD subset  
18.8 
(+6.43) 
N=6 
17.33 (+8.14) 
N=6 
1.20 
(p= .23) 
N.A. 
Impact from 
total score 
AN only 
4.3 (+3.4) 
N = 108 
2.6 (+3.0)  
N = 76 
.51 
(p< .001) 
.51 
AN+Broad 
ASD 
4.6 (+3.8) 
N = 22 
4.7 (+3.5)  
N = 18 
- .03 
(p= .94) 
ASD subset  
4.6 (+3.32) 
N=6 
4 (+ 3.4)  
N=6 
.26 
(p= .25) 
N.A. 
Emotional 
Symptoms 
AN only 
6.6 (+2.2) 
N = 108 
5.6 (+2.7) 
N = 76 
.41 
(p< .001) 
.13 
AN+Broad 
ASD 
6.9 (+2.7) 
N = 22 
6.2 (+2.9) 
N = 18 
.35 
(p= .39) 
ASD subset  
6.3 (+ 
2.65) N=6 
5.8 (+ 3)  
N=6 
.28 
(p= .45) 
N.A. 
Hyperactivity 
AN only 
5 (+2.1) 
N = 108 
4.4 (+2.3) 
N = 76 
.29 
(p= .032) 
0 
AN+Broad 
ASD 
5.3 (2.1) 
N = 22 
4.7 (1.9) 
N = 18 
.32 
(p= .16) 
ASD subset  
5.5 (+ 
2.25) N=6 
4.3 (+2.42) 
N=6 
1.49 
(p= .10) 
N.A. 
Peer 
Problems 
AN only 
2.9 (+1.9) 
N = 108 
2.9 (+1.8)  
N = 76 
0 
(p= .84)  
.25 
AN+Broad 
ASD 
4.6 (+ 2.2) 
N = 22 
5.1 (+ 2.0)  
N = 18 
- .29 
(p= .97) 
ASD subset  
4.6 (+ 2.58) 
N=6 
5.5 (+ 2.16) 
N=6 
- .61 
(p= .12) 
N.A. 
Conduct 
Problems 
AN only 
2.1 (+1.6) 
N = 108 
1.9 (+1.6) 
N = 76 
.11 
(p= .18) 
- .18 
AN+Broad 
ASD 
2.7 (+1.9) 2.2 (+1.6) .36 
N = 22 N = 18 (p= .09) 
ASD subset  
2.3 (+1.86) 
N=6 
1.6 (+1.63) 
N=6 
.56 
(p= .15) 
N.A. 
Prosocial 
AN only 
8.0 (+1.6) 
N = 108 
7.6 (+2.1)  
N = 76 
.20 
(p= .02) 
.17 
AN+Broad 
ASD 
7.5 (+2.0) 
N = 22 
7.4 (+1.9)  
N = 18 
.06 
(p= .49) 
ASD subset  
7.3 (+.81) 
N=6 
7.5 (+1.51) 
N=6 
- .52 
(p= .56) 
N.A. 
Strengths and Difficulties Questionnaire (Parent report) 
Total score 
AN only 
14.8 (+6.6) 
N = 100 
 
12.4 (+6.9) 
N = 84 
.38 
(p= .015) 
 
- .15 
AN+Broad 
ASD 
20.6 (+5.4) 
N = 23 
17.2 (+4.9) 
N=22 
.55 
(p= .006) 
ASD subset 
20.6 (+5.92) 
N=6 
16.3 (+6.43) 
N=6 
2.02 
(p= .03) 
N.A. 
Impact from 
total score 
AN only 
3.5 (+3.1) 
N = 100 
3.0 (+3.4) 
N = 84 
.14 
(p= .102) 
- .22 
AN+Broad 
ASD 
5.6 (+2.9) 
N = 23 
4.4 (+3.1) 
N=22 
.32 
(p= .112) 
ASD subset 
6.6 (+1.5) 
N=6 
4.1 (+2.71) 
N=6 
.79 
(p= .104) 
N.A. 
Emotional 
Symptoms 
AN only 
6.2 (+2.5) 
N = 100 
5 (+2.8) 
N = 84 
.44 
(p= .001) 
- .04 
AN+Broad 
ASD 
7.7 (+1.4) 
N = 23 
 
6.4 (+2.2) 
N=22 
.64 
(p= .009) 
ASD subset 
7.8 (+1.32) 
N=6 
6.5 (+2.88) 
N=6 
.56 
(p= .22) 
N.A. 
Hyperactivity 
AN only 
3.7 (+2.3) 
N = 100 
3.6 (+2.6) 
N = 84 
.04 
(p= .47) 
.04 
AN+Broad 
ASD 
4.4 (+2) 
N = 23 
4.4 (+1.8) 
N=22 
0 
(p= .62) 
ASD subset 
4.3 (+2.33) 
N=6 
3.5 (+2.34)  
N=6 
.41 
(p= .059) 
N.A. 
Peer 
Problems 
AN only 
2.5 (+2.1) 
N = 100 
2.1 (+1.6) 
N = 84 
.23 
(p= .26) 
- .24 
AN+Broad 
ASD 
4.9 (+1.7) 
N = 23 
4.0 (+2.3) 
N=22 
.37 
(p= .17) 
ASD subset 
6 (+1.26) 
N=6 
5.5 (+2.66)  
N=6 
.18 
(p= .58) 
N.A. 
Conduct 
Problems 
AN only 
2 (+1.6) 
N = 100 
1.6 (+1.5) 
N = 84 
.25 
(p= .09) 
- .48 
 Table 3. SDQ results across groups 
 
     
Strengths and 
Difficulties 
Questionnaire 
(Self report) 
    
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
 
Legend: N.A. = Not Applicable; SDQ = Strengths and Difficulties Questionnaire; 
ASD = Autism Spectrum Disorder 
 
 
 
AN+Broad 
ASD 
3.6 (+1.9) 
N = 23 
2.4 (+2) 
N=22 
.80 
(p= .003) 
ASD subset 
2.5 (+2.16) 
N=6 
.8 (+2.6)  
N=6 
.79 
(p= .04) 
N.A. 
Prosocial 
AN only 
8.4 (+1.5) 
N = 100 
7.7 (+1.9) 
N = 84 
.37 
(p= .92) 
.77 
AN+Broad 
ASD 
5.2 (+2.3) 
N = 23 
5.8 (+2.2) 
N=22 
- .26 
(p= .36) 
ASD subset 
4.5 (+1.97) 
N=6 
5.8 (+2.3)  
N=6 
- .84 
(p= .07) 
N.A. 
